Intercellular adhesion molecule-1 G241R polymorphism predicts risk of incident ischemic stroke: Atherosclerosis risk in communities study

Stroke

Volumn 41, Issue 5, 2010, Pages 1038-1040

  Volcik, Kelly A ^a   Ballantyne, Christie M ^b   Hoogeveen, Ron ^b   Folsom, Aaron R ^c   Boerwinkle, Eric ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cell adhesion molecules; Coronary heart disease; Intercellular adhesion molecule 1; Stroke

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1;

ADULT; ALLELE; ARTICLE; BRAIN ISCHEMIA; CAUCASIAN; CONTROLLED STUDY; DEATH CERTIFICATE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOSPITALIZATION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; NEGRO; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; TELEPHONE;

ATHEROSCLEROSIS; BRAIN ISCHEMIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; RISK FACTORS; STROKE;

EID: 77951767046     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.575563     Document Type: Article

References (14)

1. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis. 2003;170:191-203. (Pubitemid 37377790)
2. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999; 340:115-126.
3. McGlinchey PG, Spence MS, Patterson CC, Allen AR, Murphy G, Belton C, McKeown PP. The ICAM-1 gene K469E polymorphism is not associated with ischaemic heart disease: an investigation using family-based tests of association. Eur J Immunogenet. 2004;31:201-206.
4. Jiang H, Klein RM, Niederacher D, Du M, Marx R, Horlitz M, Boerrigter G, Lapp H, Scheffold T, Krakau I, Gulker H. C/T polymorphism of the ICAM-1 gene: a risk factor for CHD and MI. Int J Cardiol. 2002;84: 171-177.
5. Flex A, Gaetani E, Papaleo P, Straface G, Proia A, Pecorini G, Tondi P, Pola P, Pola R. Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke. 2004;35:2270-2275. (Pubitemid 39311248)
6. ARIC Investigators. The ARIC Study: design and objectives. Am J Epidemiol. 1989;129:687-702.
7. White A, Folsom A, Chambless L, Sharret A, Yang K, Conwill D, Higgins M, Williams O, Tyroler H. Community surveillance of CHD in the ARIC Study: methods and initial 2 years' experience. J Clin Epidemiol. 1996;49:223-233.
8. Rosamond W, Folsom A, Chambless L, Wang C-H, McGovern P, Howard G, Copper L, Shahar E. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the ARIC cohort. Stroke. 1999; 30:736-743.
9. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem. 1983;29:1075-1085. (Pubitemid 13106884)
10. 2+ precipitation. Clin Chem. 1982;28:1574.
11. Diamond MS, Staunton DE, de Fougerolles AR, Stacker SA, Garcia-Aquilar J, Hibbs ML, Springer TA. ICAM-1: a counter-receptor for Mac-1. J Cell Biol. 1990;111:3129.
12. Staunton DE, Dustin ML, Erickson HP, Springer TA. The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell. 1990;61:243.
13. Rothlein R, Dustin ML, Marlin SD, Springer TA. A human intercellular adhesion molecule distinct from LFA-1. J Immunol. 1986;137:1270.
14. Vischer P, Telgmann R, Schmitz B, Hasenkamp S, Schmidt-Petersen K, Beining K, Huge A, Paul M, Amarenco P, Cambien F, Brand E, Brand-Herrman SM. Molecular investigation of the functional relevance of missense variants of ICAM-1. Pharmacogenet Genomics. 2008;18: 1017-1019.